byNordic Acquisition Stock (NASDAQ: BYNOW)

Latest news for byNordic Acquisition (NASDAQ:BYNOW) Stock

byNordic Acquisition Corp is a blank check company.

byNordic Acquisition Corporation - Warrant

byNordic Acquisition Corp

Financial giants have made a conspicuous bullish move on Starbucks. Our analysis of options history for Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) revealed 11 unusual trades.
Delving into the details, we found 54% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $1,603,569, and 3 were calls, valued at $96,080.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $85.0 and $105.0 for Starbucks, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Starbucks options trades today is 4275.2 with a total volume of 5,239.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Starbucks's big money trades within a strike price range of $85.0 to $105.0 over the last 30 days.
<h3>Starbucks Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727972432_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.15</td>
<td>$10.95</td>
<td>$11.0</td>
<td>$95.00</td>
<td>$1.1M</td>
<td>6.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$4.75</td>
<td>$4.7</td>
<td>$4.7</td>
<td>$95.00</td>
<td>$210.5K</td>
<td>2.6K</td>
<td>468</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/25/24</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$98.00</td>
<td>$105.0K</td>
<td>565</td>
<td>1</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/25/24</td>
<td>$1.98</td>
<td>$1.71</td>
<td>$1.8</td>
<td>$95.00</td>
<td>$44.9K</td>
<td>554</td>
<td>3</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$4.4</td>
<td>$4.05</td>
<td>$4.05</td>
<td>$95.00</td>
<td>$40.5K</td>
<td>6.6K</td>
<td>102</td>
</tr>
</tbody>
</table>

<h3>About Starbucks</h3>
Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 38,000 stores across more than 80 countries as of the end of fiscal 2023. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.
Having examined the options trading patterns of Starbucks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Starbucks</h3>
<ul>
<li>With a trading volume of 1,666,427, the price of SBUX is down by -0.63%, reaching $95.89.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 28 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Starbucks</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $103.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Bernstein has elevated its stance to Outperform, setting a new price target at $115. 
&#x2A; An analyst from Jefferies has revised its rating downward to Underperform, adjusting the price target to $76. 
&#x2A; An analyst from TD Cowen has revised its rating downward to Buy, adjusting the price target to $110. 
&#x2A; Maintaining their stance, an analyst from TD Cowen continues to hold a Buy rating for Starbucks, targeting a price of $110. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Starbucks, maintaining a target price of $105. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Starbucks options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

SBUX

Starbucks Options Trading: A Deep Dive into Market Sentiment

Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) revealed 8 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $93,000, and 6 were calls, valued at $314,820.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $28.0 to $32.0 for Pfizer over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 7268.62 with a total volume of 11,974.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Pfizer's big money trades within a strike price range of $28.0 to $32.0 over the last 30 days.
<h3>Pfizer 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727972427_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$0.45</td>
<td>$0.44</td>
<td>$0.45</td>
<td>$30.00</td>
<td>$112.5K</td>
<td>16.8K</td>
<td>3.1K</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$5.0</td>
<td>$4.15</td>
<td>$5.0</td>
<td>$30.00</td>
<td>$60.0K</td>
<td>247</td>
<td>4</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/01/24</td>
<td>$0.32</td>
<td>$0.3</td>
<td>$0.31</td>
<td>$30.00</td>
<td>$48.4K</td>
<td>1.6K</td>
<td>296</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.62</td>
<td>$2.61</td>
<td>$2.62</td>
<td>$32.00</td>
<td>$47.1K</td>
<td>256</td>
<td>180</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$0.49</td>
<td>$0.48</td>
<td>$0.49</td>
<td>$28.50</td>
<td>$47.1K</td>
<td>656</td>
<td>6.9K</td>
</tr>
</tbody>
</table>

<h3>About Pfizer</h3>
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
In light of the recent options history for Pfizer, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Pfizer</h3>
<ul>
<li>With a trading volume of 10,723,798, the price of PFE is down by -0.93%, reaching $28.34.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 26 days from now.</li>
</ul>
<h3>Expert Opinions on Pfizer</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $45.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $45. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Behind the Scenes of Pfizer's Latest Options Trends

Deep-pocketed investors have adopted a bearish approach towards United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in X usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for United States Steel. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 52% bearish. Among these notable options, 13 are puts, totaling $1,496,460, and 4 are calls, amounting to $133,520.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $25.0 to $52.5 for United States Steel during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in United States Steel's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to United States Steel's substantial trades, within a strike price spectrum from $25.0 to $52.5 over the preceding 30 days.
<h3>United States Steel Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727972422_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$9.2</td>
<td>$9.0</td>
<td>$9.2</td>
<td>$40.00</td>
<td>$183.9K</td>
<td>5.6K</td>
<td style="text-align: right;">802</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$9.2</td>
<td>$9.0</td>
<td>$9.2</td>
<td>$40.00</td>
<td>$183.9K</td>
<td>5.6K</td>
<td style="text-align: right;">602</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$9.2</td>
<td>$9.0</td>
<td>$9.2</td>
<td>$40.00</td>
<td>$183.9K</td>
<td>5.6K</td>
<td style="text-align: right;">402</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.75</td>
<td>$15.6</td>
<td>$15.9</td>
<td>$50.00</td>
<td>$157.4K</td>
<td>7.3K</td>
<td style="text-align: right;">101</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$16.0</td>
<td>$15.6</td>
<td>$16.0</td>
<td>$50.00</td>
<td>$156.8K</td>
<td>7.3K</td>
<td style="text-align: right;">100</td>
</tr>
</tbody>
</table>

<h3>About United States Steel</h3>
United States Steel Corp operates primarily in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It primarily serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.
<h3>Present Market Standing of United States Steel</h3>
<ul>
<li>With a volume of 768,153, the price of X is up 0.9% at $34.91. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>Professional Analyst Ratings for United States Steel</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $40.52333333333333.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on United States Steel with a target price of $41. 
&#x2A; Showing optimism, an analyst from GLJ Research upgrades its rating to Buy with a revised price target of $38. 
&#x2A; Showing optimism, an analyst from JP Morgan upgrades its rating to Overweight with a revised price target of $42. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for United States Steel with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

This Is What Whales Are Betting On United States Steel

WIIM

AMZN

NFLX

PARA

Shares of streaming companies are trading lower after Amazon announced they will ramp up their Prime Video advertising spend.

In 1989, a couple from Long Island took a chance on an unclaimed storage unit for just $100, as reported by a CNBC article. They didn't expect to find a piece of movie history tucked away under some old blankets – a 1976 Lotus Esprit, used in the James Bond film The Spy Who Loved Me.
The couple, who had no clue what they stumbled upon, initially planned to fix the car's roof and do some minor work. But while hauling it home, truckers on the road started radioing them, letting them know they had something much more valuable – a James Bond car. After hearing this, the husband rented the movie and realized they were sitting on a treasure.&nbsp;
Don't Miss:
<ul>
<li>Unlock a $400 billion opportunity by investing in the future of EV infrastructure on<a href="https://www.benzinga.com/money/dunamis-1"> this startup already valued at $50 million with just $500</a>.</li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
Ironically, the couple had reportedly never even seen a Bond film.&nbsp;
Years later, after some cosmetic touch-ups, they auctioned the car in 2013. That's when Elon Musk entered the picture, paying nearly $1 million for the Lotus – $997,000. Musk, who grew up watching the Bond movie, said, "It was amazing as a little kid to watch James Bond drive the Lotus Esprit off a pier and have it transform into a submarine."
In a statement to auto blog Jalopnik, Musk said, "I was disappointed to learn that it can&#8217;t transform. What I&#8217;m going to do is upgrade it with a Tesla electric powertrain and try to make it transform for real."
Interestingly, the car, nicknamed "Wet Nellie," was originally converted into a functional submarine for the movie, costing over $100,000. While it couldn't drive on land, it was fully capable of underwater action with propellers and ballast tanks. Instead of wheels, it had "articulated fins.&#8221;&nbsp;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's an opportunity to invest at $1,000 for only $0.50/share today.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Musk's fascination with the Lotus Esprit didn't end at its purchase. He stated that the car significantly shaped the futuristic design of Tesla's Cybertruck, unveiled in 2019.&nbsp;
Musk <a href="https://x.com/elonmusk/status/1197638937109336066">posted on X</a> that the Cybertruck's sharp, angular design was "influenced partly" by the iconic Bond car, writing: "Cybertruck design influenced partly by The Spy Who Loved Me." He attached a YouTube clip of the movie.&nbsp;
Musk's desire to combine cutting-edge electric vehicle technology with a design inspired by his childhood memories of James Bond highlights the seamless blend of nostalgia and innovation at the heart of Tesla's boldest creations.
Read Next:
<ul>
<li>Amid the ongoing EV revolution, previously overlooked low-income communities<a href="https://www.benzinga.com/money/dunamis-1"> now harbor a huge investment opportunity at just $500.</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

News

Elon Musk Paid $1 Million For A 1976 Car That Inspired Cybertruck's Design – Seller Originally Bought It For Just $100 In A Storage Unit Sale

Morgan Stanley analyst Brian Nowak reiterated Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with an Overweight rating and a <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings" target="_blank" rel="noreferrer noopener">$210&nbsp;price target</a>.
Amazon traded at 22 times Nowak&#8217;s 2026 free cash flow, representing 29% growth (fiscal 2024-2026 free cash flow per share CAGR). He said this is a ~30% discount to Amazon&#8217;s mega-cap tech peer median growth-adjusted multiple on a growth-adjusted basis.
Also Read: <a href="https://www.benzinga.com/news/24/10/41162084/amazon-prime-video-ramps-up-ads-taking-on-netflix-and-disney-in-streaming-battle" target="_blank" rel="noreferrer noopener">Amazon Prime Video Ramps Up Ads, Taking on Netflix and Disney+ in Streaming Battle</a>
The price target implies paying 20 times fiscal 2027 free cash flow for 24% growth (fiscal 2025-2027 free cash flow per share CAGR) and 0.8 times on a growth-adjusted basis, a ~20% discount to Amazon&#8217;s mega-cap tech peer median growth-adjusted multiple of 1.1 times.
Nowak noted the tactical risk to fourth-quarter EBIT but is buying weakness into fiscal 2025 as the profit challenges are temporary and not structural.
Nowak said Amazon&#8217;s growing focus on lower-priced, lower-margin essentials drives merchandise margin pressure, which is holding back the near-term slope of its North American retail profit ramp. Expected discounting in a competitive holiday season creates further near-term uncertainty, he said.
According to the analyst, Amazon makes low-priced essentials profitable and the cost to serve still leads to $8-$9 free cash flow per share. Corporate efficiencies could lead to $2 billion-$4 billion of further savings, and Project Kuiper and headcount models speak to minimal headwinds here.
Nowak said Amazon management&#8217;s recent letter outlining an increased focus on efficiency should lead to a further EBIT cushion and upside in fiscal 2025.
Project Kuiper is likely to be manageable from a P&amp;L-impact perspective, Nowak said. He noted Amazon&#8217;s growing net cash balance creates a higher probability of capital returns in fiscal 2025.
Nowak projected fiscal 2024 revenue of $633.96 billion and EPS of $4.80. He expects fiscal 2025 revenue of $ 697.94 billion and EPS of $5.93.
AMZN Price Action:&nbsp;Amazon stock is down 1.15% at $182.64 at publication Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41163890/alibaba-and-jd-com-battle-for-hong-kong-shoppers-stocks-slid-after-stimulus-rally" target="_blank" rel="noreferrer noopener">Alibaba and JD.com Battle for Hong Kong Shoppers, Stocks Slide After Stimulus Rally</a></li>
</ul>
Photo: Shutterstock

Price Target

Reiteration

Analyst Ratings

Trading Ideas

Amazon's Profitable Essential Merchandise, Efficiency Gains Set To Drive Growth: Analyst

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday.
Following the market opening Thursday, the Dow traded up 0.16% to 17,954.10 while the NASDAQ gained 0.43% to 18,002.24. The S&amp;P 500 also fell, dropping, 0.03% to 5,707.82.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41161390/wall-streets-most-accurate-analysts-spotlight-on-3-defensive-stocks-delivering-high-divi">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Information technology shares jumped by 1.3% on Thursday.
In trading on Thursday, materials shares dipped by 0.9%.
Top Headline
The S&amp;P Global services PMI was revised lower to 55.2 in September compared to a preliminary reading of 55.4, and versus a reading of 55.7 in August.
The S&amp;P Global U.S. composite PMI sipped to 54 in September versus a preliminary reading of 54.4, and versus 54.6 in August.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Elevai Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) shares shot up 67% to $0.1416 after the company announced its subsidiary, Elevai Biosciences, filed two patent applications for its lead candidate, EL-22, aimed at treating muscle loss in obese patients.</li>
<li>Shares of Theriva Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#NASDAQ">TOVX</a>) got a boost, surging 47% to $1.8253 after the company announced the Data and Safety Monitoring Committee&#8217;s review outcome for its Phase 1b/2a clinical trial of SYN-004. The DSMC has recommended the study proceed to enroll cohort 3.</li>
<li>AMTD Digital Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) shares were also up, gaining 39% to $0.1601.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares dropped 19% to $6.21 following first-quarter results.</li>
<li>Shares of Kaixin Holdings &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) were down 11% to $0.3042. Shares of US-listed Chinese stocks traded lower as the sector pulled back from recent strength. These companies rallied after the People&#8217;s Bank of China announced a new stimulus package ahead of the Golden Week holidays.</li>
<li>Ingevity Corporation &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVT#NYSE">NGVT</a>) was down, falling 14% to $32.22 as the company said John Fortson has departed as president and CEO and from the board of directors of the company, effective as of Oct. 2.</li>
</ul>
Commodities In commodity news, oil traded up 4.3% to $73.14 while gold traded down 0.1% at $2,667.50.
Silver traded up 0.3% to $32.015 on Thursday, while copper fell 2% to $4.5540.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.79%, Germany's DAX fell 0.69% and France's CAC 40 fell 0.97%. Spain's IBEX 35 Index rose 0.18%, while London's FTSE 100 fell 0.07%.
Producer prices in the Eurozone rose 0.6% month-over-month in August compared to a revised 0.7% increase in July. The HCOB Eurozone composite PMI was revised higher to 49.6 in September versus a preliminary reading of 48.9.
The S&amp;P Global UK services PMI declined to 52.4 in September from 53.7 in the previous month, while German services PMI fell to 50.6 in September from 51.2 a month ago.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 gaining 1.97%, Hong Kong's Hang Seng Index falling 1.47% and India's BSE Sensex dipping 2.10%.
The au Jibun Bank Japan services PMI was revised lower to 53.1 for September, versus a preliminary reading of 53.9.
Economics
<ul>
<li>U.S. initial jobless claims increased by 6,000 from the prior week to 225,000 during the week ended Sept. 28, compared to market estimates of 220,000.</li>
<li>The S&amp;P Global services PMI was revised lower to 55.2 in September compared to a preliminary reading of 55.4, and versus a reading of 55.7 in August.</li>
<li>The S&amp;P Global U.S. composite PMI sipped to 54 in September versus a preliminary reading of 54.4, and versus 54.6 in August.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41160677/top-3-consumer-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Consumer Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

ANGO

ELAB

KXIN

NGVT

TOVX

Crude Oil Jumps Over 4%; US Services PMI Revised Lower

YPF Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ypf#NYSE">YPF</a>), Argentina&#39;s state-owned energy company, has announced that it will be lowering fuel prices across the country, starting from Oct. 1, 2024. The company announced a 4% reduction in gasoline prices and a 5% reduction in diesel prices. However, the pump prices will reflect a 1% reduction in gasoline prices and 2% in diesel prices. The devaluation of the Argentine peso and an increase in taxes led to a 3% rise in fuel prices, which partially reduced the full benefit of the price cut.
<h2>YPF&#39;s Fair Pricing Strategy</h2>
YPF considers several factors before setting the prices, including local and international market dynamics as well as fuel production costs as it intends to stick to a fair pricing strategy for fuels. Per the company&#39;s statement, the reduction in fuel prices is a reflection of the declining trend in the global Brent crude oil prices. The state-owned energy firm has reportedly lowered fuel prices for the first time since 2019.
Argentina has witnessed a cumulative 51% rise in gasoline prices so far. According to source, the year-over-year increase in gas prices stood at a staggering 340% in September. YPF has successfully struck a balance between local fuel prices and international prices over the past eight months, which should enable it to make future price adjustments based on international Brent crude prices alongside other local factors associated with costs.
<h2>Economic Challenges in Argentina</h2>
Argentina has been grappling with a high rate of inflation and instability in the value of its currency. As such, the reduction in fuel prices may have a significant impact on the economy. Easing up fuel prices by YPF should reduce the burden on Argentina&#39;s consumers and its businesses by lowering transportation expenses. As Argentina&#39;s largest oil company, YPF&#39;s decision carries substantial weight and may influence other companies in the industry to do the same, benefitting consumers all over Argentina.&nbsp;
<h2>YPF&#39;s Zacks Rank and Key Picks</h2>
Currently, YPF carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the energy&nbsp;sector are&nbsp;PEDEVCO Corp. (AMEX:PED),&nbsp;Archrock Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aroc#NYSE">AROC</a>) and VAALCO Energy (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/egy#NYSE">EGY</a>). PEDEVCO and Archrock presently sport a Zacks Rank #1 (Strong Buy) each, whereas VAALCO Energy carries a Zacks Rank #2 (Buy).
PEDEVCO is engaged in the acquisition and development of energy assets in the United States and Pacific Rim countries. PED stands to benefit from its holdings in the Permian Basin, one of the most prolific oil-producing regions in the United States, as well as in the D-J Basin in Colorado, which includes more than 150 high-quality drilling locations. Combined with bullish oil prices, this is expected to boost the company&#39;s production and overall profitability.
Archrock is an energy infrastructure company based in the United States, with a focus on midstream natural gas compression. It provides natural gas contract compression services and generates stable fee-based revenues.
VAALCO Energy is an independent energy company, involved in upstream business operations with a diversified presence in Africa and Canada and have a large inventory of drilling locations in the premium Acreage.
<a href="https://www.zacks.com/stock/news/2345294/ypf-reduces-fuel-prices-amid-inflationary-pressures-in-argentina?cid=CS-BENZ-FT-analyst_blog|company_news_energy_sector-2345294">To read this article on Zacks.com click here.</a>

Mid Cap

Penny Stocks

Contracts

Small Cap

AROC

YPF Reduces Fuel Prices Amid Inflationary Pressures in Argentina

JP Morgan analyst Jimmy Bhullar maintains Unum Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>) with a Overweight and lowers the price target from $65 to $63.

JP Morgan Maintains Overweight on Unum Gr, Lowers Price Target to $63

JP Morgan analyst Tessa Romero maintains Scholar Rock Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) with a Overweight and lowers the price target from $20 to $18.

SRRK

JP Morgan Maintains Overweight on Scholar Rock Holding, Lowers Price Target to $18

Cantor Fitzgerald analyst Brett Knoblauch reiterates TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) with a Overweight and maintains $10 price target.

WULF

Cantor Fitzgerald Reiterates Overweight on TeraWulf, Maintains $10 Price Target

JP Morgan analyst Arun Jayaram maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Overweight and lowers the price target from $23 to $22.

JP Morgan Maintains Overweight on NOV, Lowers Price Target to $22

<a href="https://blog.youtube/news-and-events/tall-updates-coming-to-shorts/" title="https://blog.youtube/news-and-events/tall-updates-coming-to-shorts/">https://blog.youtube/news-and-events/tall-updates-coming-to-shorts/</a>

GOOG

GOOGL

YouTube Says Starting Oct 15, Can Upload Shorts Up To 3 Minutes Long

JP Morgan analyst Jeffrey Zekauskas maintains RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) with a Neutral and raises the price target from $120 to $126.

JP Morgan Maintains Neutral on RPM Intl, Raises Price Target to $126

JP Morgan analyst Jimmy Bhullar maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Neutral and raises the price target from $220 to $222.

JP Morgan Maintains Neutral on Reinsurance Gr, Raises Price Target to $222

Equinix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) shares are trading lower on Thursday.
On Tuesday, the company disclosed a joint venture with GIC and Canada <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41115011/equinix-agrees-to-form-greater-than-15b-jv-to-expand-hyperscale-data-centers-in-the-u-s-and-suppor" rel="noreferrer noopener">Pension Plan Investment Board (CPP Investments)</a>.
All parties have made equity commitments, and the JV plans to raise more than $15 billion in investable capital through equity and debt.
As per the terms, CPP Investments and GIC will each hold a 37.5% equity stake in the joint venture, while Equinix will own 25%.
Equinix&#8217;s current hyperscale joint venture portfolio in Europe, Asia-Pacific, and the Americas has over $8 billion in committed investment. When fully built out, it aims to deliver more than 725 MW of power capacity across 35+ facilities.
The JV will accelerate the expansion of Equinix&#8217;s xScale data center portfolio, which supports hyperscale companies in enhancing their core deployments at Equinix&#8217;s IBX data centers.
Once fully realized, this new JV will nearly triple the investment capital of the xScale program, driven by the growing demand for AI and cloud services.
Also Read: <a href="https://www.benzinga.com//node/41168255">Rezolve AI Shares Surge On Microsoft Partnership Announcement: What You Need To Know</a>
Equinix expects the JV to acquire land and develop new xScale facilities on several 100+ MW campuses in the U.S., adding over 1.5 gigawatts of capacity for hyperscale customers.
The joint venture&#8217;s closing, pending regulatory approvals, is expected by the fourth quarter of 2024.
Adaire Fox-Martin, CEO and President, Equinix stated, &#8220;As the world&#8217;s leading companies build out their infrastructure to support key workloads such as artificial intelligence, they require the combination of large-scale data center footprints optimized for AI training and interconnection nodes for the most efficient inferencing.&#8221;
&#8221;Our xScale and IBX offerings are uniquely positioned to address this business need, enabling companies to realize the powerful potential of AI.&#8221;
Investors can gain exposure to the stock via&nbsp;Pacer Data &amp; Infrastructure Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRVR#NYSE">SRVR</a>) and Elevation Series Trust SRH REIT Covered Call ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRHR#NYSE">SRHR</a>).
Price Action: EQIX shares are down 0.98% at $877.92 at the last check Thursday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/40752686/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a></li>
</ul>

EQIX

SRHR

Pacer Benchmark Data & Infrastructure Real Estate SCTR ETF

SRVR

Equinix Turbocharges AI And Cloud Growth With $15B Joint Venture: Expanding xScale Data Centers Worldwide

Deutsche Bank analyst David Huang maintains RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) with a Buy and raises the price target from $132 to $140.

Deutsche Bank Maintains Buy on RPM Intl, Raises Price Target to $140

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $45.0, with a high estimate of $50.00 and a low estimate of $41.00. Observing a 8.88% increase, the current average has risen from the previous average price target of $41.33. 
<img src="https://www.benzinga.com/files/images/story/2024/1727971285_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Calix's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Christian Schwab</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Scott Searle</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$44.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$41.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Calix. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Calix compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Calix's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Calix's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CALX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Calix analyst ratings.</a>
<h2>About Calix</h2>
Calix Inc develops, market and sell Calix cloud, systems and software platforms to enable service providers of all types and sizes to innovate and transform. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East &amp; Africa, Europe, Asia Pacific and other markets.
<h3>A Deep Dive into Calix's Financials</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Calix's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -24.09% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Calix's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -4.02% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -1.06%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Calix's ROA stands out, surpassing industry averages. With an impressive ROA of -0.86%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.01, Calix adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CALX

A Closer Look at 9 Analyst Recommendations For Calix

During the last three months, 6 analysts shared their evaluations of Blue Bird (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Blue Bird, presenting an average target of $62.0, a high estimate of $72.00, and a low estimate of $48.00. This current average has increased by 9.1% from the previous average price target of $56.83. 
<img src="https://www.benzinga.com/files/images/story/2024/1727971263_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Blue Bird among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Craig Irwin</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$48.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Michael Shlisky</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$67.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Adam Seiden</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Sherif El-Sabbahy</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$66.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Blue Bird. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Blue Bird compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Blue Bird's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Blue Bird's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BLBD/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Blue Bird analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Blue Bird</h2>
Blue Bird Corp is an American bus manufacturing company. It has its operations in two segments. The Bus segment involves the design, engineering, manufacture and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. It carries its operations in the United States, Canada, and the rest of the world. The majority of its sales are derived from the United States through its bus manufacturing business.
<h3>Blue Bird's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Blue Bird's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 13.28%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Blue Bird's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 8.61%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Blue Bird's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 23.62%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Blue Bird's ROA excels beyond industry benchmarks, reaching 6.21%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.71.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLBD

Unveiling 6 Analyst Insights On Blue Bird

Across the recent three months, 5 analysts have shared their insights on ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated ModivCare and provided 12-month price targets. The average target is $24.0, accompanied by a high estimate of $35.00 and a low estimate of $14.00. A decline of 25.58% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1727971246_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive ModivCare. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Petusky</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Michael Petusky</td>
<td>Barrington Research</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brooks O'Neil</td>
<td>Lake Street</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Brian Tanquilut</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$14.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Michael Petusky</td>
<td>Barrington Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$35.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to ModivCare. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of ModivCare compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of ModivCare's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MODV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on ModivCare analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering ModivCare: A Closer Look</h2>
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
<h3>Financial Insights: ModivCare</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: ModivCare's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -0.12%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: ModivCare's net margin is impressive, surpassing industry averages. With a net margin of -18.46%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -177.34%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -7.49%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 127.23, ModivCare faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

byNordic Acquisition

News

Latest news for byNordic Acquisition (NASDAQ:BYNOW) Stock